<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05544</article-id><article-id pub-id-type="doi">10.7554/eLife.05544</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>Angiopoietin-like proteins stimulate HSPC development through interaction with Notch receptor signaling.</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-21906"><name><surname>Lin</surname><given-names>Michelle I</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21907"><name><surname>Price</surname><given-names>Emily N</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21908"><name><surname>Boatman</surname><given-names>Sonja</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21909"><name><surname>Hagedorn</surname><given-names>Elliott J</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21910"><name><surname>Trompouki</surname><given-names>Eirini</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21911"><name><surname>Satishchandran</surname><given-names>Sruthi</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21912"><name><surname>Carspecken</surname><given-names>Charles W</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21913"><name><surname>Uong</surname><given-names>Audrey</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21914"><name><surname>DiBiase</surname><given-names>Anthony</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21915"><name><surname>Yang</surname><given-names>Song</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21916"><name><surname>Canver</surname><given-names>Matthew C</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21917"><name><surname>Dahlberg</surname><given-names>Ann</given-names></name><aff><institution content-type="dept">Pediatric Oncology, Clinical Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21918"><name><surname>Lu</surname><given-names>Zhigang</given-names></name><aff><institution content-type="dept">Department of Physiology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18058"><name><surname>Zhang</surname><given-names>Cheng Cheng</given-names></name><aff><institution content-type="dept">Department of Physiology and Developmental Biology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4030"><name><surname>Orkin</surname><given-names>Stuart H</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21919"><name><surname>Bernstein</surname><given-names>Irwin D</given-names></name><aff><institution content-type="dept">Pediatric Oncology, Clinical Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21920"><name><surname>Aster</surname><given-names>Jon C</given-names></name><aff><institution content-type="dept">Department of Pathology</institution>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20435"><name><surname>White</surname><given-names>Richard M</given-names></name><aff><institution content-type="dept">Department of Cancer Biology</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3910"><name><surname>Zon</surname><given-names>Leonard I</given-names></name><aff><institution content-type="dept">Stem Cell Program and Division of Hematology/Oncology</institution>, <institution>Howard Hughes Medical Institute, Boston's Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>zon@enders.tch.harvard.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1042"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Los Angeles</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>02</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e05544</elocation-id><supplementary-material><ext-link xlink:href="elife-05544-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>09</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Lin et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Lin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Angiopoietin-like proteins <italic>(angptls)</italic> are capable of <italic>ex vivo</italic> expansion of mouse and human hematopoietic stem and progenitor cells (HSPCs). Despite this intriguing ability, their mechanism is unknown. Here, we show that <italic>angptl2</italic> overexpression is sufficient to expand definitive HSPCs in zebrafish embryos. <italic>Angptl1/2</italic> are required for definitive hematopoiesis and vascular specification of the hemogenic endothelium. The loss-of-function phenotype is reminiscent of the <italic>notch</italic> mutant <italic>mindbomb (mib)</italic> and a strong genetic interaction occurs between <italic>angptls</italic> and <italic>notch</italic>. Overexpressing <italic>angptl2</italic> rescues <italic>mib</italic> while overexpressing <italic>notch</italic> rescues <italic>angptl1/2</italic> morphants. Gene expression studies in Angptl2-stimulated CD34<sup>+</sup> cells showed a strong Myc activation signature and <italic>myc</italic> overexpression in <italic>angptl1/2</italic> morphants or <italic>mib</italic> restored HSPCs formation. Angptl2 can increase Notch activation in cultured cells and Angptl receptor interacted with Notch to regulate Notch cleavage. Together our data provide insight to the <italic>angptl</italic>-mediated <italic>notch</italic> activation through receptor interaction and subsequent activation of <italic>myc</italic> targets.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>angiopoietin-like proteins</kwd><kwd>hematopoietic stem and progenitor cells</kwd><kwd>LILRB2</kwd><kwd>myc</kwd><kwd>notch</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Leonard I Zon, I am a founder and stockholder of Fate, Inc. and Scholar Rock, and a scientific advisor for Stemgent.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All zebrafish were housed at the Karp Aquatic Resource Program Facility at Boston Children's Hospital. All protocols were approved by the Animal Care and Use Committee at Boston Children's Hospital and by the Institutional Animal Care and Use Committee (protocol 11-10-2069R).</p></fn></fn-group></back></article>